Impact of Mobile Health Interactive Software on Tuberculosis Outcomes; The Call for Life (CFLU-TB) Project
Condition: Tuberculosis Intervention: Other: Call for Life Uganda Sponsor: Infectious Diseases Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 14, 2021 Category: Research Source Type: clinical trials
Treatment Success and Safety of 4 Weeks of Daily Rifapentine and Isoniazid (1HP) vs. 12 Weeks of Weekly Rifapentine and Isoniazid (3HP) for Prevention of Tuberculosis in HIV-uninfected Individuals (1v3HP for TPT in HIV-uninfected Individuals)
Condition: Tuberculosis Interventions: Drug: Rifapentine 600 mg and INH 300 mg; Drug: Rifapentine 900 mg and INH 900 mg Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2021 Category: Research Source Type: clinical trials
Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary Tuberculosis
Conditions: TB - Tuberculosis; HIV/AIDS Intervention: Sponsors: University of Stellenbosch; New York University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2021 Category: Research Source Type: clinical trials
Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide
Condition: Tuberculosis, Pulmonary Interventions: Drug: rifampicin; Drug: pyrazinamide; Drug: HRZE; Drug: HR Sponsors: University Hospital, Linkoeping; Karolinska University Hospital; Ryhov County Hospital; Kalmar County Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2021 Category: Research Source Type: clinical trials
DIAGNOSIS of PULMONARY TUBERCULOSIS Through HUMAN BREATH (TBENOSE)
Conditions: Tuberculosis, Pulmonary; HIV Seropositivity Interventions: Device: Tor Vergata Electronic Nose (TV eNose); Other: Survey & Physical Exam; Diagnostic Test: TB LAMP test; Other: Sputum Samples; Other: Chest X-Ray; Other: Follow Up 5 days after beginning of Tx.; Other: Follow Up & 15 days after beginning of Tx.; Other: Follow Up & 3...
Source: ClinicalTrials.gov - December 24, 2020 Category: Research Source Type: clinical trials
Impact of the Respiratory Isolation on the Quality of Life in Patients Hospitalized for Tuberculosis or COVID-19
Conditions: Tuberculosis; Covid19 Intervention: Other: Impact of respiratory isolation on quality of life Sponsor: Assistance Publique - Hôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2020 Category: Research Source Type: clinical trials
